Could This FDA Approval Boost AbbVie’s Stock?
Last month, one of its anti-psychotic drugs received approval from the Food and Drug Administration for another indication.
Mindfully Curated
Last month, one of its anti-psychotic drugs received approval from the Food and Drug Administration for another indication.
Currency headwinds are fading faster than expected.
PayPal is astonishingly cheap, at least from one valuation perspective.
Buying beaten-down stocks and holding for the long haul is a proven strategy for success.
With their stock prices rising, these companies’ yields are becoming less attractive.
Which overseas e-commerce company is the better investment?
This stock is a proven long-term play, but it’s struggling lately.
The company projects to deliver powerful dividend growth for the next several years.
The company has an illustrious past and is making every effort to have a bright future too.
Mixed results from Goldman Sachs and Morgan Stanley paint a complicated picture.
How did this iconic big-box retailer end up in its current situation?
Avalanche’s new partnership with Amazon Web Services could provide a strong catalyst for future long-term growth.
A question with multiple meanings.
Technology that enables an unprecedented, high-resolution look for all structural variants in our genes that are known to cause cancer can outperform standard tests used today for common blood cancers like leukemia, researchers report.
Regulatory mechanisms of nutrient-dependent neuronal development can be explored at the molecular level with the Drosophila C4da neuron located in the fruit flies’ larvae. The hyperarborization phenotype was not caused by low concentrations of amino ac…
Despite only about 25% of car travel happening after dark, almost half of fatal accidents occur at night. As our vehicles become more advanced and even autonomous, the ways of detecting and avoiding these collisions must evolve too. Current systems are…
The company’s tenant-related headwinds seem to be fading.
The car dealer is facing a potential bankruptcy. Can it survive?
Is this top MSO play a worthwhile bargain or a value trap?
Big tech could be only just beginning to encroach on semiconductor designers’ turf.